Cargando…

A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy

Multidrug resistance (MDR), which is common in colorectal cancer (CRC), induces high mortality in patients. Due to its robust and selective apoptosis induction in some CRC cells with MDR, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is attractive as a novel tool for CRC therapy. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhao, She, Tianshan, Yang, Hao, Su, Tao, Shi, Qiuxiao, Tao, Ze, Feng, Yanru, Yang, Fen, Cheng, Jingqiu, Lu, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176698/ https://www.ncbi.nlm.nih.gov/pubmed/35635308 http://dx.doi.org/10.1080/10717544.2022.2079766

Ejemplares similares

Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer
por: She, Tianshan, et al.
Publicado: (2021)

Targeted Delivery to Tumor-associated Pericytes via an Affibody with High Affinity for PDGFRβ Enhances the in vivo Antitumor Effects of Human TRAIL
por: Tao, Ze, et al.
Publicado: (2017)

A single nucleotide mutation drastically increases the expression of tumor-homing NGR-TNFα in the E. coli M15-pQE30 system by improving gene transcription
por: Chen, Jie, et al.
Publicado: (2021)

Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects
por: Yang, Hao, et al.
Publicado: (2018)

Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment
por: Zhong, Yi, et al.
Publicado: (2019)

PDGFRβ-specific affibody-directed delivery of a photosensitizer, IR700, is efficient for vascular-targeted photodynamic therapy of colorectal cancer
por: Shi, Qiuxiao, et al.
Publicado: (2017)

From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
por: Draghiciu, Oana, et al.
Publicado: (2011)

Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib
por: Ke, Changhong, et al.
Publicado: (2020)

Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
por: El-Zawahry, Ahmed, et al.
Publicado: (2005)

Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo
por: Zhang, Zhen, et al.
Publicado: (2016)

Targeted PDT Agent Eradicates TrkC Expressing Tumors via Photodynamic Therapy (PDT)
por: Kue, Chin Siang, et al.
Publicado: (2014)

Dual-Agent Photodynamic Therapy with Optical Clearing Eradicates Pigmented Melanoma in Preclinical Tumor Models
por: Pires, Layla, et al.
Publicado: (2020)

TRAIL: not just for tumors anymore?
por: Benedict, Chris A., et al.
Publicado: (2012)

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice
por: Hylander, Bonnie L, et al.
Publicado: (2005)

Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells
por: Szliszka, Ewelina, et al.
Publicado: (2012)

Effect of ALA–mediated photodynamic therapy in combination with tumor necrosis factor–related apoptosis–inducing ligand (TRAIL) on bladder cancer cells
por: Szliszka, Ewelina, et al.
Publicado: (2011)

Irradiated tumor cell–derived microparticles mediate tumor eradication via cell killing and immune reprogramming
por: Wan, Chao, et al.
Publicado: (2020)

Simple Multifunctional PTX@Ce6 Nanomedicine for Eradicating Tumor in the Combination of Photodynamic Therapy and Metronomic Chemotherapy
por: Li, Mengxuan, et al.
Publicado: (2022)

Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models
por: Chen, Lei, et al.
Publicado: (2019)

Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer
por: Hu, Zhiwei, et al.
Publicado: (2016)

Heparan sulfate promotes TRAIL-induced tumor cell apoptosis
por: Luo, Yin, et al.
Publicado: (2023)

In vivo generated human CAR T cells eradicate tumor cells
por: Agarwal, Shiwani, et al.
Publicado: (2019)

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
por: Piranlioglu, Raziye, et al.
Publicado: (2019)

5-aminolaevulinic acid (5-ALA) accumulates in GIST-T1 cells and photodynamic diagnosis using 5-ALA identifies gastrointestinal stromal tumors (GISTs) in xenograft tumor models
por: Sasaki, Makiko, et al.
Publicado: (2021)

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
por: Zhang, Bin, et al.
Publicado: (2007)

Platelet mediated TRAIL delivery for efficiently targeting circulating tumor cells
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2020)

Enhancement of tumor lethality of ROS in photodynamic therapy
por: Ming, Lan, et al.
Publicado: (2020)

Preclinical evaluation of (68)Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma
por: Cai, Huawei, et al.
Publicado: (2023)

Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells
por: Yang, Hao, et al.
Publicado: (2013)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors
por: Creighton, Chad J, et al.
Publicado: (2006)

Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor
por: Pan, Hong, et al.
Publicado: (2020)

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells
por: Potu, Harish, et al.
Publicado: (2019)

Tumor xenograft animal models for esophageal squamous cell carcinoma
por: Lee, Nikki P., et al.
Publicado: (2018)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016)

Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy
por: Hong, Liang, et al.
Publicado: (2022)

In Vivo Detection of Circulating Cancer-Associated Fibroblasts in Breast Tumor Mouse Xenograft: Impact of Tumor Stroma and Chemotherapy
por: Lu, Tao, et al.
Publicado: (2023)

Photodynamic Therapy with Tumor Cell Discrimination through RNA-Targeting Ability of Photosensitizer
por: Xu, Yuan, et al.
Publicado: (2021)

Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy
por: de Looff, Margot, et al.
Publicado: (2019)

Overcoming Hypoxic-Resistance of Tumor Cells to TRAIL-Induced Apoptosis through Melatonin
por: Lee, You-Jin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_06fji5lo7q6u7nthls20puv3d1